With landlines down, small town stayed connected with Verizon Frontline
WASHINGTON, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — As a small, historic mining town in…
Month: January 2022
Sorenson Communications Announces Initiatives to Support American Sign Language Interpreters
Reaffirms ongoing commitment to Deaf, underrepresented communities SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE)…
Loxam Renews Its High Availability Managed SD-WAN Network With GTT
– The network agreement covers more than 115 of Loxam’s European sites MCLEAN, Va., Jan….
HMNC Brain Health Expands International Patent Portfolio with Two Stress-axis Related Substances for Major Depressive Disorder
In-Licensing arrangement with the renowned Max Planck Society, extends patent protection for clinical research and…
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations
WOBURN, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Immunovant Appoints Mark Levine as Chief Legal Officer
Mr. Levine adds valuable experience to the leadership team as Immunovant accelerates the development of…
Biomea Fusion Announces First Patient Dosed
BMF-219 is the first irreversible covalent menin inhibitor to enter the clinic Phase I trial…
Outlook Therapeutics Provides a Corporate Update and Business Outlook
Outlook Therapeutics advancing first ever ophthalmic formulation of bevacizumab towards new U.S. FDA Biologics License…
CinDome Pharma announces successful completion of thorough QT study of CIN-102 (deudomperidone) in healthy subjects.
CIN-102, Deudomperidone, is a novel, deuterium-containing, peripherally selective dopamine (D2/D3) receptor antagonist. Study demonstrated that…
Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
SEATTLE and VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Identity Defined Security Alliance Announces New Membership Types and Approval as (ISC)2 Submitter Partner
End users now have opportunity to participate in IDSA activities via contributor or corporate memberships,…
Ambient.ai Emerges from Stealth, Introduces Computer Vision Intelligence Platform for Physical Security Industry
The company launches with $52 million in funding and five of the largest US tech…
Nozomi Networks Guardian NSG-M Receives ANSSI-CSPN Certification
The National Cybersecurity Agency of France (ANSSI) has granted Nozomi Networks solution Guardian NSG-M first-level…
Leading Canadian Home Improvement Retailer Extends Fortinet Secure SD-WAN Across 1,100+ Network Edges
Fortinet Secure SD-WAN Enables Home Hardware to Enhance Business Critical Application Performance with Centralized Management…
One Size Fits All with the Right Device Management Solution
By Nadav Avni, Chief Marketing Officer at Radix Technologies For any workforce to maintain high-performance…
5 Key Considerations For Your Cybersecurity Strategy
By CyberHat 5 key considerations for your cybersecurity strategy Cybersecurity. Not only do all organizations need…
CyberWave Annuonced Partnership with WEYU
Seoul, Korea, Jan 8, 2022 – (ACN Newswire) – In last December, CyberWave annuonced Partnership…
Rubix establishes strategic partnership with Grounded & FINAO to facilitate ESG applications using the Rubix public blockchain
“We are excited to work with Grounded & FINAO to promote global ESG impact using…
ONSTON Announces ONSTON Metaverse Platform Development Plan for 2022
Hong Kong, Jan 8, 2022 – (ACN Newswire) – ONSTON, a new virtual reality metaverse…